Anixa Biosciences (ANIX) Change in Acquisitions & Divestments (2011 - 2025)

Anixa Biosciences (ANIX) has 15 years of Change in Acquisitions & Divestments data on file, last reported at $8.3 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments fell 52.03% year-over-year to $8.3 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $49.2 million (down 27.66% YoY) and the FY2025 annual result came in at $49.2 million, down 27.66% from the prior year.
• Change in Acquisitions & Divestments eased to $8.3 million in Q4 2025, from $10.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $20.1 million in Q1 2024 to a low of $1.0 million in Q2 2021.
• A 5-year average of $9.0 million and a median of $8.6 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments tumbled 84.16% — and 2023, when it jumped 1057.16%.
• Tracing ANIX's Change in Acquisitions & Divestments over 5 years: stood at $8.9 million in 2021, then plunged by 84.16% to $1.4 million in 2022, then jumped by 1057.16% to $16.3 million in 2023, then grew by 6.21% to $17.3 million in 2024, then tumbled by 52.03% to $8.3 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $8.3 million (Q4 2025), $10.9 million (Q3 2025), and $14.3 million (Q2 2025), per Business Quant data.